An overview of synthetic peptide compounds studied for their roles in cytoprotective signaling, actin dynamics, and cellular repair pathways. This category covers BPC-157, TB-500, and the Wolverine Blend, compounds with substantial peer-reviewed research in rodent and in vitro models of cellular homeostasis.
Cellular repair research encompasses the biological mechanisms by which tissues respond to damage, stress, and perturbation, including wound healing cascades, angiogenesis, inflammation resolution, extracellular matrix remodeling, and cytoskeletal reorganization. Synthetic peptide tool compounds are used in this field to probe specific signaling pathways in controlled experimental settings.
BPC-157 and TB-500 represent two mechanistically distinct but complementary research compounds in this space. BPC-157 is studied primarily for its interactions with the nitric oxide system and growth factor signaling, while TB-500: a fragment of the endogenous cytoskeletal protein Thymosin Beta-4, is studied for its role in actin sequestration and cell migration regulation.
Both compounds have generated substantial bodies of peer-reviewed literature, primarily in rodent models and cell culture systems. The published research spans gastroenterology, orthopedic biology, cardiovascular research, and neuroscience, reflecting the broad biological relevance of the signaling pathways these compounds modulate in laboratory settings.
BPC-157 research has examined interactions with both eNOS and nNOS pathways. Studies investigate how NO system modulation relates to cytoprotective signaling in gastrointestinal and vascular tissue models.
TB-500's primary research mechanism involves binding to G-actin monomers, modulating the G-actin/F-actin equilibrium. This affects cell motility, migration, and cytoskeletal reorganization in wound healing models.
Both compounds have been studied in the context of new blood vessel formation. Published research examines VEGF-mediated and VEGF-independent angiogenic signaling in endothelial cell models and rodent assays.
BPC-157 has been studied for interactions with growth hormone receptors and EGF receptor pathways. Research examines downstream MAPK and PI3K/Akt signaling in cellular proliferation and survival models.
Research models examine NF-κB pathway modulation, pro-inflammatory cytokine expression, and resolution phase signaling in tissue explant and cell culture systems treated with these compounds.
BPC-157 and TB-500 are studied because they provide relatively specific handles on complex biological processes, cytoprotection and cytoskeletal dynamics, respectively, that are difficult to probe with conventional pharmacological tools. Their peptide nature makes them suitable for cell culture systems where small molecule alternatives may introduce confounding cytotoxicity.
The breadth of published BPC-157 research across organ systems reflects the widespread relevance of the nitric oxide and growth factor pathways it appears to modulate. Researchers studying these pathways in diverse tissue contexts find BPC-157 a useful experimental reference compound, particularly given the extensive comparative literature available from decades of animal model studies.
TB-500's value lies in its selectivity for the actin regulatory pathway. Because the G-actin/F-actin equilibrium is central to cell motility, cytokinesis, and wound healing, TB-500 provides a research tool for investigating the contribution of actin dynamics to specific biological outcomes without the complexity of genetic manipulation approaches.
The Wolverine Blend enables researchers to study potential pathway interactions and synergistic effects between cytoprotective and actin-regulatory signaling in a single experimental preparation.
A synthetic 15-amino acid peptide derived from a sequence in human gastric juice protein. The most extensively studied compound in this category, with published research spanning gastrointestinal cytoprotection, tendon and ligament biology, CNS signaling, and cardiovascular models. Studied for interactions with the NO system, growth hormone receptors, and multiple growth factor pathways.
View BPC-157 Profile →A synthetic fragment of Thymosin Beta-4 containing the actin-binding domain (LKKTETQ). TB-500 is studied for its role in G-actin sequestration, cell migration, and angiogenesis. Shorter and more tractable than full-length Tβ4, it is used as a research tool in wound healing models, cardiac tissue studies, and cell motility assays.
A standardized co-formulation of BPC-157 and TB-500 for researchers studying combined cytoprotective and actin-regulatory pathway activity. Enables single-preparation experimental designs for pathway interaction studies. Formulated at defined ratios with full batch documentation for both component compounds.
For short synthetic peptides like BPC-157 (15 amino acids) and TB-500 (17 amino acids), the primary purity concerns are truncated synthesis sequences, oxidized methionine residues (where applicable), and racemization at chiral centers. These impurities can produce distinct biological activity profiles, making high-purity compounds essential for reproducible research results.
HPLC purity analysis at ≥99% is the baseline standard for research-grade peptides in this category. Mass spectrometry confirmation ensures the correct molecular weight and fragmentation pattern, distinguishing the target compound from co-eluting impurities that may not be fully resolved by HPLC alone.
All tissue repair compounds supplied by Lone Star Peptide Co. are verified by independent third-party laboratories. Batch-specific COAs are included with every order. Researchers requiring raw chromatographic data for institutional procurement documentation may request this at time of order.
⚠ FOR RESEARCH USE ONLY, All compounds are intended exclusively for in vitro and laboratory research. Not approved by the FDA for human consumption or therapeutic use. Nothing on this page constitutes medical advice or clinical guidance. Researchers are responsible for all applicable regulatory compliance prior to use.